Short walks beat one big workout for Kids' health?
NCT ID NCT04469790
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether taking short walks throughout the day is better for kids at risk for type 2 diabetes than one longer exercise session. Researchers will measure blood sugar, insulin, and thinking skills in 188 children aged 8-11 with overweight or obesity. The goal is to find simple ways to reduce the harmful effects of sitting too much.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Behavioral intervention: interrupting sitting with short walks vs. a single bout of sustained exercise
- What this could lead to
- If it works, this could point toward simple daily habits to help prevent type 2 diabetes in children with overweight or obesity.
- What could go wrong
- This is a small, early-stage study (188 participants) testing short-term effects in a lab setting. Results may not apply to real-world, long-term health outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 188 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2022
- Expected to finish
-
Aug 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
8 to 11 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Age 8-11 years-old 2. Good general health 3. BMI≥85th percentile Exclusion Criteria: 1. Significant cardiac or pulmonary disease likely to or resulting in hypoxia or decreased perfusion 2. Diagnosis of T2DM and/or presence of other endocrinologic disorders leading to obesity (e.g., Cushing Syndrome) 3. Current or past anti-psychotic drug use that would affect metabolism 4. Non-diet treatment for hypertension or dyslipidemia 5. Precocious puberty and/or receiving androgen and estrogen therapy 6. Medication use known to affect body composition/weight
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AFFECT are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Britni Ryan Belcher, PhD, MPH
Los Angeles, California, 90032, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Custom knee guides put to the test in obese patients
- A pill for obesity? early human trial puts MDR-001 to the test
- Can a weekly shot help people who still struggle with weight after bariatric surgery?
- Do GLP-1 Weight-Loss drugs change how teens eat and feel?
- Can video games calm anxious teens?
- Can electrical muscle stimulation boost exercise benefits after menopause?